Investigation Report on China Cattle Encephalon Glycoside and Ignotin Market, 2010-2019
Description
According to WHO, such noncommunicable diseases as cardiovascular disease, cancer, chronic respiratory disease, diabetes have become severe threats to human health in the 21st century. According to the Report on Cardiovascular Diseases in China (2013), cardiovascular disease is the leading killer of Chinese people with 3.5 million dying from it each year. Two in every five deaths are caused by cardiovascular disease and every ten seconds witnesses the death of one people caused by cardiovascular disease. According to statistics, by 2020, the number of people dying from cardiovascular disease will reach 4 million each year. But the growth of mortality of cardiovascular disease has slowed down since 2009. Featuring high mortality, disability, incidence and medical risk, cardiovascular disease has become a major public health issue in China. According to ADI-China, the incidence of dementia reaches up to 5.6% among people aged above 65 and over 25% among those aged above 85. And the number of new cases is about 0.3 million each year. In 2014, the incidence of dementia in China was equal to that in the world with about 10 million Chinese suffering from it.
After purchasing Dupromise Medicine Co., Ltd, Jilin Sihuan Pharmaceutical Co., Ltd got the production license of cattle encephalon glycoside and ignotin injection. Cattle encephalon glycoside and ignotin develops fast after entering China with sales value reaching CNY 681 million in 2014 and CAGR during the period of 2010-2014 surpassing 110%. As members of Sihuan Pharmaceutical Holdings Group Ltd, Jilin Sihuan Pharmaceutical Co., Ltd and Jilin Sichang Pharmaceutical Co., Ltd dominate the market with the former having a higher market share of nearly 90% for sales value in 2014. With aging population in China, the incidences of cardiovascular disease and dementia grow year by year. Therefore, cattle encephalon glycoside and ignotin is expected to enjoy a vast demand in China.
Readers can get at least the following information through this report:
According to WHO, such noncommunicable diseases as cardiovascular disease, cancer, chronic respiratory disease, diabetes have become severe threats to human health in the 21st century. According to the Report on Cardiovascular Diseases in China (2013), cardiovascular disease is the leading killer of Chinese people with 3.5 million dying from it each year. Two in every five deaths are caused by cardiovascular disease and every ten seconds witnesses the death of one people caused by cardiovascular disease. According to statistics, by 2020, the number of people dying from cardiovascular disease will reach 4 million each year. But the growth of mortality of cardiovascular disease has slowed down since 2009. Featuring high mortality, disability, incidence and medical risk, cardiovascular disease has become a major public health issue in China. According to ADI-China, the incidence of dementia reaches up to 5.6% among people aged above 65 and over 25% among those aged above 85. And the number of new cases is about 0.3 million each year. In 2014, the incidence of dementia in China was equal to that in the world with about 10 million Chinese suffering from it.
After purchasing Dupromise Medicine Co., Ltd, Jilin Sihuan Pharmaceutical Co., Ltd got the production license of cattle encephalon glycoside and ignotin injection. Cattle encephalon glycoside and ignotin develops fast after entering China with sales value reaching CNY 681 million in 2014 and CAGR during the period of 2010-2014 surpassing 110%. As members of Sihuan Pharmaceutical Holdings Group Ltd, Jilin Sihuan Pharmaceutical Co., Ltd and Jilin Sichang Pharmaceutical Co., Ltd dominate the market with the former having a higher market share of nearly 90% for sales value in 2014. With aging population in China, the incidences of cardiovascular disease and dementia grow year by year. Therefore, cattle encephalon glycoside and ignotin is expected to enjoy a vast demand in China.
Readers can get at least the following information through this report:
- market size of cattle encephalon glycoside and ignotin in China
- competitive landscape of cattle encephalon glycoside and ignotin market in China
- price of cattle encephalon glycoside and ignotin made by different enterprises in China
- market outlook of cattle encephalon glycoside and ignotin in China
- manufacturers of anti-dementia drugs
- investors/research institutions interested in Chinese medicine market
- -any interest in Chinese medicine market, please contact CRI for customized survey service
1 RELATED CONCEPTS OF CATTLE ENCEPHALON GLYCOSIDE AND IGNOTIN
1.1 Indication
1.2 Overview of Global Market
2 MARKET PROFILE OF CATTLE ENCEPHALON GLYCOSIDE AND IGNOTIN IN CHINA
2.1 Patent and Approval Information of Cattle Encephalon Glycoside and Ignotin in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES OF CATTLE ENCEPHALON GLYCOSIDE AND IGNOTIN IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF CATTLE ENCEPHALON GLYCOSIDE AND IGNOTIN IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF CATTLE ENCEPHALON GLYCOSIDE AND IGNOTIN IN CHINA, 2010-2014
6 REFERENCE PRICE OF CATTLE ENCEPHALON GLYCOSIDE AND IGNOTIN IN CHINESE HOSPITALS IN 2014
6.1 Jilin Sihuan Pharmaceutical Co., Ltd
6.2 Jilin Sichang Pharmaceutical Co., Ltd
7 MAJOR MANUFACTURERS OF CATTLE ENCEPHALON GLYCOSIDE AND IGNOTIN IN CHINESE MARKET, 2010-2014
7.1 Jilin Sihuan Pharmaceutical Co., Ltd
7.2 Jilin Sichang Pharmaceutical Co., Ltd
8 MARKET OUTLOOK OF CATTLE ENCEPHALON GLYCOSIDE AND IGNOTIN IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
TABLE OF SELECTED CHARTS
Chart Patent Status of Cattle Encephalon Glycoside and Ignotin in China
Chart Approval Information of Cattle Encephalon Glycoside and Ignotin in China
Chart Sales Status of Cattle Encephalon Glycoside and Ignotin in China
Chart Sales Value of Cattle Encephalon Glycoside and Ignotin in China, 2010-2014
Chart Sales Value of Cattle Encephalon Glycoside and Ignotin in Some Regions in China, 2010-2014
Chart Sales Volume of Cattle Encephalon Glycoside and Ignotin in China, 2010-2014
Chart Sales Volume of Cattle Encephalon Glycoside and Ignotin in Some Regions in China, 2010-2014
Chart Sales Value and Market Share of Cattle Encephalon Glycoside and Ignotin Made by Jilin Sihuan in China, 2010-2014
Chart Sales Value and Market Share of Cattle Encephalon Glycoside and Ignotin Made by Jilin Sichang in China, 2010-2014
Chart Price of Cattle Encephalon Glycoside and Ignotin Made by Jilin Sihuan Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Cattle Encephalon Glycoside and Ignotin Made by Jilin Sichang Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
1.1 Indication
1.2 Overview of Global Market
2 MARKET PROFILE OF CATTLE ENCEPHALON GLYCOSIDE AND IGNOTIN IN CHINA
2.1 Patent and Approval Information of Cattle Encephalon Glycoside and Ignotin in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES OF CATTLE ENCEPHALON GLYCOSIDE AND IGNOTIN IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF CATTLE ENCEPHALON GLYCOSIDE AND IGNOTIN IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF CATTLE ENCEPHALON GLYCOSIDE AND IGNOTIN IN CHINA, 2010-2014
6 REFERENCE PRICE OF CATTLE ENCEPHALON GLYCOSIDE AND IGNOTIN IN CHINESE HOSPITALS IN 2014
6.1 Jilin Sihuan Pharmaceutical Co., Ltd
6.2 Jilin Sichang Pharmaceutical Co., Ltd
7 MAJOR MANUFACTURERS OF CATTLE ENCEPHALON GLYCOSIDE AND IGNOTIN IN CHINESE MARKET, 2010-2014
7.1 Jilin Sihuan Pharmaceutical Co., Ltd
7.2 Jilin Sichang Pharmaceutical Co., Ltd
8 MARKET OUTLOOK OF CATTLE ENCEPHALON GLYCOSIDE AND IGNOTIN IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
TABLE OF SELECTED CHARTS
Chart Patent Status of Cattle Encephalon Glycoside and Ignotin in China
Chart Approval Information of Cattle Encephalon Glycoside and Ignotin in China
Chart Sales Status of Cattle Encephalon Glycoside and Ignotin in China
Chart Sales Value of Cattle Encephalon Glycoside and Ignotin in China, 2010-2014
Chart Sales Value of Cattle Encephalon Glycoside and Ignotin in Some Regions in China, 2010-2014
Chart Sales Volume of Cattle Encephalon Glycoside and Ignotin in China, 2010-2014
Chart Sales Volume of Cattle Encephalon Glycoside and Ignotin in Some Regions in China, 2010-2014
Chart Sales Value and Market Share of Cattle Encephalon Glycoside and Ignotin Made by Jilin Sihuan in China, 2010-2014
Chart Sales Value and Market Share of Cattle Encephalon Glycoside and Ignotin Made by Jilin Sichang in China, 2010-2014
Chart Price of Cattle Encephalon Glycoside and Ignotin Made by Jilin Sihuan Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Cattle Encephalon Glycoside and Ignotin Made by Jilin Sichang Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
